l 636499 has been researched along with azathioprine in 1 studies
*Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) [MeSH]
*Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) [MeSH]
| Studies (l 636499) | Trials (l 636499) | Recent Studies (post-2010) (l 636499) | Studies (azathioprine) | Trials (azathioprine) | Recent Studies (post-2010) (azathioprine) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 15,489 | 1,746 | 3,080 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alijani, MR; Foegh, ML; Helfrich, GB; Khirabadi, BS; Ramwell, PW | 1 |
1 other study(ies) available for l 636499 and azathioprine
| Article | Year |
|---|---|
Prolongation of cardiac allograft survival with the PAF antagonist BN-52021 and the thromboxane receptor antagonists L640035 and L636499.
Topics: Animals; Azathioprine; Dibenzothiepins; Graft Survival; Heart Transplantation; Prostaglandin Antagonists; Rats; Time Factors; Transplantation, Homologous | 1985 |